Page results
-
Dr Neil Graham is a consultant neurologist based at the National Hospital for Neurology and Neurosurgery. His sub-specialist interests are in traumatic brain injury (‘TBI’), sometimes termed ‘concussion’, neurodegenerative dementia, including conditions such as chronic traumatic encephalopathy (‘CTE’), and the development and evaluation of health technologies.
-
Our general medicine services aim to diagnose and advise patients with a range of medical problems.
-
Nasopharyngeal cancer is a rare type of cancer that affects the part of the throat connecting the back of the nose to the back of the mouth (the pharynx).
-
Hypopharyngeal cancer is a rare type of cancer that affects the inlet to the oesophagus (gullet).
-
The Acute Stroke Unit (ASU) is the next step of care for stroke patients who come to the Hyper-acute Stroke Unit (HASU) at UCLH.
-
The autonomic unit provides a comprehensive national tertiary clinical service (combining both investigation and management) for a wide variety of autonomic disorders.
-
Our Brain Tumour Service is a pioneering specialist centre offering high-quality treatment and care to patients with all forms of brain or spinal tumours.
-
The movement disorders group specialises in the assessment, diagnosis and treatment of people with diseases such as Parkinson’s disease, dystonia, tremor, myoclonus and chorea.
-
The department of Neuroanaesthesia and Critical Care has 30 substantive consultant anaesthetists and intensivists as well as approximately 40 resident doctors. It is responsible for the provision of anaesthetic services in the six operating theatres, neuroradiology and the interventional MRI operating suite as well as critical care services at NHNN.
-
This information is for patients who are having radiotherapy for a base of skull tumour. It explains what the treatment involves, describes side-effects you may experience during and after treatment, and how best to cope with them.
File results
-
FOI/2024/0480 - Freedom of Information (FOI) requests 2020/21-2023/24
-
FOI/2022/0655 - GIDS patients who have been prescribed GnRH analogues
-
FOI/2023/0418 - GIDS service patient referrals and treatment
-
FOI/2024/0368 - Treatment in renal cell carcinoma
-
FOI/2024/0482 - Medical device/ enterprise application Integration/ data warehouse systems
-
FOI/2024/0489 - Late starts for elective theatre sessions
-
FOI/2024/0491 - Breast cancer treatment
-
FOI/2024/0490 - Continuous pre-emptive flow model for A&E patients
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0488 - Emergency Preparedness, Resilience and Response Framework (EPRR) cycle of preparedness/ exercise dates